Efficacy of cilostazol on inhibition of platelet aggregation, inflammation and myonecrosis in acute coronary syndrome patients undergoing percutaneous coronary intervention: The ACCEL-LOADING-ACS (ACCELerated Inhibition of Platelet Aggregation, Inflammation and Myonecrosis by Adjunctive Cilostazol Loading in Patients With Acute Coronary Syndrome) study

Int J Cardiol. 2015:190:370-5. doi: 10.1016/j.ijcard.2015.04.180. Epub 2015 Apr 23.
No abstract available

Keywords: Acute coronary syndrome; Cilostazol; Inflammation; Myonecrosis; Platelet.

Publication types

  • Letter
  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Coronary Syndrome / diagnosis
  • Acute Coronary Syndrome / drug therapy*
  • Acute Coronary Syndrome / surgery*
  • Aged
  • Cilostazol
  • Drug Administration Schedule
  • Female
  • Humans
  • Inflammation / diagnosis
  • Inflammation / drug therapy
  • Inflammation / surgery
  • Male
  • Middle Aged
  • Percutaneous Coronary Intervention / trends*
  • Platelet Aggregation / drug effects*
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Function Tests / methods
  • Prospective Studies
  • Tetrazoles / administration & dosage*
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors
  • Tetrazoles
  • Cilostazol